Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 2171032, 7 pages
http://dx.doi.org/10.1155/2016/2171032
Research Article

In Vitro and In Vivo Anti-Helicobacter Activities of Eryngium foetidum (Apiaceae), Bidens pilosa (Asteraceae), and Galinsoga ciliata (Asteraceae) against Helicobacter pylori

1Microbiology and Pharmacology Laboratory, Department of Biochemistry, Faculty of Science, University of Dschang, P.O. Box 67, Dschang, Cameroon
2Gastroenterology Department, Laquintinie Hospital of Douala, P.O. Box 4035, Douala, Cameroon

Received 7 June 2016; Accepted 31 July 2016

Academic Editor: Gail B. Mahady

Copyright © 2016 Laure brigitte Kouitcheu Mabeku et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. N. Ndip, A. E. Malange, J. F. T. Akoachere, W. G. Mackay, V. P. K. Titanji, and L. T. Weaver, “Helicobacter pylori antigens in the faeces of asymptomatic children in the Buea and Limbe health districts of Cameroon: a pilot study,” Tropical Medicine and International Health, vol. 9, no. 9, pp. 1036–1040, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. L. M. Brown, “Helicobacter pylori: epidemiology and routes of transmission,” Epidemiologic Reviews, vol. 22, no. 2, pp. 283–297, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. B. E. Lacy and J. Rosemore, “Helicobacter pylori: ulcers and more: the beginning of an era,” Journal of Nutrition, vol. 131, no. 10, pp. 2789S–2793S, 2001. View at Google Scholar · View at Scopus
  4. B. D. Gold, “Helicobacter pylori infection in children,” Current Problems of Pediatric and Adolescent Health Care, vol. 31, pp. 247–266, 2001. View at Google Scholar
  5. J. S. C. Hoffman and D. R. Cave, “Treatment of Helicobacter pylori,” Current Opinion in Gastroenterology, vol. 17, no. 1, pp. 30–34, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. N. Broutet, S. Tchamgoué, E. Pereira, H. Lamouliatte, R. Salamon, and F. Mégraud, “Risk factors for failure of Helicobacter pylori therapy—results of an individual data analysis of 2751 patients,” Alimentary Pharmacology & Therapeutics, vol. 17, no. 1, pp. 99–109, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. J. M. Meyer, N. P. Silliman, W. Wang et al., “Risk factors for Helicobacter pylori resistance in the United States: the surveillance of H. pylori Antimicrobial resistance partnership (SHARP) study, 1993–1999,” Annals of Internal Medicine, vol. 136, no. 1, pp. 13–24, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. O. A. Aboderin, R. A. Abdul, W. O. Babatunde et al., “Antibiotic resistance of Helicobacter pylori from patients in Ile-Ife, South-west, Nigeria,” African Health Science, vol. 7, no. 3, pp. 143–147, 2007. View at Google Scholar
  9. T. Kanamaru, Y. Nakano, Y. Toyoda et al., “In vitro and in vivo antibacterial activities of TAK-083, an agent for treatment of Helicobacter pylori infection,” Antimicrobial Agents and Chemotherapy, vol. 45, no. 9, pp. 2455–2459, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. G. B. Mahady, S. L. Pendland, G. S. Yun, Z.-Z. Lu, and A. Stoia, “Ginger (Zingiber officinale Roscoe) and the Gingerols Inhibit the Growth of Cag A+ Strains of Helicobacter pylori,” Anticancer Research, vol. 23, no. 5A, pp. 3699–3702, 2003. View at Google Scholar · View at Scopus
  11. G. B. Mahady, S. L. Pendland, A. Stoia, and L. R. Chadwick, “In vitro susceptibility of Helicobacter pylori to isoquinoline alkaloids from Sanguinaria canadensis and Hydrastis canadensis,” Phytotherapy Research, vol. 17, no. 3, pp. 217–221, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Marone, L. Bono, E. Leone, S. Bona, E. Carretto, and L. Perversi, “Bactericidal activity of Pistacia lentiscus mastic gum against Helicobacter pylori,” Journal of Chemotherapy, vol. 13, no. 6, pp. 611–614, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. N. I. Belogortseva, J. Y. Yoon, and K. H. Kim, “Inhibition of Helicobacter pylori hemagglutination by polysaccharide fractions from roots of Panax ginseng,” Planta Medica, vol. 66, no. 3, pp. 217–220, 2000. View at Publisher · View at Google Scholar · View at Scopus
  14. Y.-K. Yee and M. W.-L. Koo, “Anti-Helicobacter pylori activity in Chinese tea: in vitro study,” Alimentary Pharmacology & Therapeutics, vol. 14, no. 5, pp. 635–638, 2000. View at Publisher · View at Google Scholar · View at Scopus
  15. C. E. Haas, D. E. Nix, and J. J. Schentag, “In vitro selection of resistant Helicobacter pylori,” Antimicrobial Agents and Chemotherapy, vol. 34, no. 9, pp. 1637–1641, 1990. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Krakowka, K. A. Eaton, and R. D. Leunk, “Antimicrobial therapies for Helicobacter pylori infection in gnotobiotic piglets,” Antimicrobial Agents and Chemotherapy, vol. 42, no. 7, pp. 1549–1554, 1998. View at Google Scholar · View at Scopus
  17. M. B. Skirrow, “Campylobacter and Helicobacter enteritis gastritis,” in Medical Microbiology, D. Greenwood, R. C. B. Slack, J. F. Peutherer, and J. P. Duguid, Eds., pp. 353–361, ELBS, 14th edition, 1992. View at Google Scholar
  18. A. A. Aly, “Biosynthesis of phenolic compounds and water soluble vitamins in cilantro (Eryngium foetidum L.) plantlets as affected by low doses of gamma irradiation,” Fascicula Biologie, vol. 2, pp. 356–361, 2010. View at Google Scholar
  19. C. Ramcharan, “Culantro: a much utilized, little understood herb,” in Perspectives on New Crops and New Uses, J. Janick, Ed., pp. 506–509, ASHS Press, Alexandria, Va, USA, 1999. View at Google Scholar
  20. J. H. A. Paul, C. E. Seaforth, and T. Tikasingh, “Eryngium foetidum L.: a review,” Fitoterapia, vol. 82, no. 3, pp. 302–308, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Yarnell, “Home field advantage,” Chemical & Engineering News, vol. 82, no. 23, p. 33, 2004. View at Google Scholar
  22. D. P. Lingaraju, M. S. Sudarshana, C. Mahendra, and K. Poornachandra Rao, “Phytochemical screening and antimicrobial activity of leaf extracts of Eryngium foetidum L. (Apiaceae),” Indo American Journal of Pharmaceutical Research, vol. 6, no. 2, pp. 4339–4344, 2016. View at Google Scholar
  23. M. T. Sáenz, M. A. Fernández, and M. D. García, “Antiinflammatory and analgesic properties from leaves of Eryngium foetidum L. (Apiaceae),” Phytotherapy Research, vol. 11, no. 5, pp. 380–383, 1997. View at Google Scholar · View at Scopus
  24. O. R. Simon and N. Singh, “Demonstration of anticonvulsant properties of an aqueous extract of Spirit Weed (Eryngium foetidum L.),” The West Indian Medical Journal, vol. 35, no. 2, pp. 121–125, 1986. View at Google Scholar · View at Scopus
  25. B. K. Singh, Y. Ramakrishna, and S. V. Ngachan, “Spiny coriander (Eryngium foetidum L.): a commonly used, neglected spicing-culinary herb of Mizoram, India,” Genetic Resources and Crop Evolution, vol. 61, no. 6, pp. 1085–1090, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. J.-Q. Huang, S. Sridhar, and R. H. Hunt, “Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis,” The Lancet, vol. 359, no. 9300, pp. 14–22, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. S. P. N. Mativandlela, N. Lall, and J. J. M. Meyer, “Antibacterial, antifungal and antitubercular activity of (the roots of) Pelargonium reniforme (CURT) and Pelargonium sidoides (DC) (Geraniaceae) root extracts,” South African Journal of Botany, vol. 72, no. 2, pp. 232–237, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Parekh and S. V. Chanda, “In vitro antimicrobial activity and phytochemical analysis of some Indian medicinal plants,” Turkish Journal of Biology, vol. 31, no. 1, pp. 53–58, 2007. View at Google Scholar · View at Scopus
  29. V. Y. Miendje Deyi, P. Bontems, J. Vanderpas et al., “Multicenter survey of routine determinations of resistance of Helicobacter pylori to antimicrobials over the last 20 years (1990 to 2009) in Belgium,” Journal of Clinical Microbiology, vol. 49, no. 6, pp. 2200–2209, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. M. M. Cowan, “Plant products as antimicrobial agents,” Clinical Microbiology Reviews, vol. 12, no. 4, pp. 564–582, 1999. View at Google Scholar · View at Scopus
  31. V. Kuete and T. Efferth, “Cameroonian medicinal plants: pharmacology and derived natural products,” Frontiers in Pharmacology, vol. 1, article 123, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. N. F. Tanih, C. Dube, E. Green et al., “An African perspective on Helicobacter pylori: prevalenc of human infection, drug resistance, and alternative approaches to treatment,” Annals of Tropical Medicine and Parasitology, vol. 103, no. 3, pp. 189–204, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Wu and J. Sung, “Treatment of Helicobacter pylori infection,” Hong Kong Medical Journal, vol. 5, no. 2, pp. 145–149, 1999. View at Google Scholar · View at Scopus
  34. R. N. Ndip, A. E. Malange Takang, J. E. A. Ojongokpoko et al., “Helicobacter pylori isolates recovered from gastric biopsies of patients with gastro-duodenal pathologies in Cameroon: current status of antibiogram,” Tropical Medicine and International Health, vol. 13, no. 6, pp. 848–854, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. C. E. Manyi-Loh, A. M. Clarke, N. F. Mkwetshana, and R. N. Ndip, “Treatment of Helicobacter pylori infections: mitigating factors and prospective natural remedies,” African Journal of Biotechnology, vol. 9, no. 14, pp. 2032–2042, 2010. View at Google Scholar · View at Scopus
  36. L. B. Rice, “Unmet medical needs in antibacterial therapy,” Biochemical Pharmacology, vol. 71, no. 7, pp. 991–995, 2006. View at Publisher · View at Google Scholar · View at Scopus